JP2019507165A5 - - Google Patents

Download PDF

Info

Publication number
JP2019507165A5
JP2019507165A5 JP2018545843A JP2018545843A JP2019507165A5 JP 2019507165 A5 JP2019507165 A5 JP 2019507165A5 JP 2018545843 A JP2018545843 A JP 2018545843A JP 2018545843 A JP2018545843 A JP 2018545843A JP 2019507165 A5 JP2019507165 A5 JP 2019507165A5
Authority
JP
Japan
Prior art keywords
imatinib
administered
dose
day
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018545843A
Other languages
English (en)
Japanese (ja)
Other versions
JP6914957B2 (ja
JP2019507165A (ja
Filing date
Publication date
Priority claimed from SE1650260A external-priority patent/SE539450C2/en
Application filed filed Critical
Publication of JP2019507165A publication Critical patent/JP2019507165A/ja
Publication of JP2019507165A5 publication Critical patent/JP2019507165A5/ja
Application granted granted Critical
Publication of JP6914957B2 publication Critical patent/JP6914957B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018545843A 2016-02-29 2017-02-27 脳卒中の処置における使用のためのイマチニブ Active JP6914957B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1650260-1 2016-02-29
SE1650260A SE539450C2 (en) 2016-02-29 2016-02-29 Imatinib for use in the treatment of stroke
PCT/SE2017/050183 WO2017151043A1 (en) 2016-02-29 2017-02-27 Imatinib for use in the treatment of stroke

Publications (3)

Publication Number Publication Date
JP2019507165A JP2019507165A (ja) 2019-03-14
JP2019507165A5 true JP2019507165A5 (enExample) 2020-04-09
JP6914957B2 JP6914957B2 (ja) 2021-08-04

Family

ID=59744327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018545843A Active JP6914957B2 (ja) 2016-02-29 2017-02-27 脳卒中の処置における使用のためのイマチニブ

Country Status (17)

Country Link
US (2) US10953010B2 (enExample)
EP (1) EP3423060B1 (enExample)
JP (1) JP6914957B2 (enExample)
CN (2) CN108697711A (enExample)
AU (1) AU2017227515B2 (enExample)
DK (1) DK3423060T3 (enExample)
ES (1) ES2895432T3 (enExample)
HR (1) HRP20211621T1 (enExample)
HU (1) HUE056798T2 (enExample)
LT (1) LT3423060T (enExample)
PL (1) PL3423060T3 (enExample)
PT (1) PT3423060T (enExample)
RS (1) RS62465B1 (enExample)
RU (1) RU2739382C1 (enExample)
SE (1) SE539450C2 (enExample)
SI (1) SI3423060T1 (enExample)
WO (1) WO2017151043A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10617756B2 (en) * 2017-01-05 2020-04-14 Shimojani, LLC Drug regimen for treatment of cerebral ischemia
CN114306342B (zh) * 2020-09-30 2024-06-28 江苏先声药业有限公司 一种注射用伊马替尼盐的药物组合物及其制备方法
WO2023086768A1 (en) * 2021-11-09 2023-05-19 Truebinding, Inc. Methods of treating or inhibiting cardiovascular diseases
EP4311539A1 (en) 2022-07-29 2024-01-31 Artorange Ltd. Imatinib formulation for parenteral administration
US20250000934A1 (en) 2023-06-28 2025-01-02 Pharmazz, Inc. Lyophilized sovateltide-based injectable formulation and method for preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148074A (en) * 2005-05-10 2013-02-28 Novartis Ag Pharmaceutical compositions comprising imatinib and a release retardant
US8147828B2 (en) 2006-04-17 2012-04-03 Ludwig Institute For Cancer Research Methods and compositions for modulation of blood-neural barrier
US7977348B2 (en) * 2006-04-27 2011-07-12 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
MX2008008447A (es) * 2006-10-26 2008-09-15 Sicor Inc Proceso para la preparacion de imatinib.
US20100136094A1 (en) 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
JP2012521984A (ja) * 2009-03-27 2012-09-20 モリーク ピーティーイー リミテッド 細胞成長を促進するための治療

Similar Documents

Publication Publication Date Title
JP2019507165A5 (enExample)
JP2017048208A5 (enExample)
AR050418A1 (es) Dosificacion fija de anticuerpos her
JP2015518818A5 (enExample)
JP2011105733A5 (enExample)
JP2017506624A5 (enExample)
JP2018507243A5 (enExample)
RU2010147287A (ru) Комбинированная композиция
JP2017531033A5 (enExample)
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2019536761A5 (enExample)
JP2017533220A5 (enExample)
CN105106245A (zh) Akkermansia muciniphila BAA-835菌株的应用
JP2015172095A5 (enExample)
JP2009501801A5 (enExample)
JP2019501226A5 (enExample)
JP2018531605A5 (enExample)
JP2018521007A5 (enExample)
JP2019526559A5 (enExample)
JP2017524721A5 (enExample)
JP2012505830A5 (enExample)
JP2004538319A5 (enExample)
JP2005519936A5 (enExample)
JP2018506533A5 (enExample)
JP2018505901A5 (enExample)